Investor Center

Soligenix, Inc.’s common stock is listed on Nasdaq under the symbol SNGX. Stockholders and interested parties are urged to contact our main office in Princeton, New Jersey at 609-538-8200 or send an e-mail to ir@nullsoligenix.com for further information.



Dr. Christopher Schaber, President & CEO of Soligenix Inc. talks about the company’s activities. Video provided courtesy of Thomson Reuters Insider Network

Company Presentations

Financial and Corporate Governance Information

Literature Request

If you would like to receive our Investor Relations Packet, including reprints of scientific publications relating to our products, click here. Thank you for your interest.

Save

Save

Save